Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, has been awarded a design win and received a volume order for its
Author: Hordon Kim
Ideal Power completes patented B-TRAN driver for customer sampling program
Ideal Power, a pioneer to develop and commercialize highly efficient and broadly patented B-TRAN™ bi-directional power switches, announced that, in collaboration with The University of Texas at Austin’s Semiconductor Power Electronics Center, it has finalized the development and fabrication of a new
[Design Focus] Vesta Thrive for natural human centric lighting
Credo unveils optical DSP for high-performance data centers and 5G wireless networks
Credo, a global innovation leader in high performance, low power serial connectivity solutions, announced Seagull 200, the next product in Credo’s SEAGULL Platform, to support the ever-growing bandwidth demand on datacenter and wireless networks. The Seagull 200 Optical DSP supports high performance
[Design Focus] Bluetooth Low Energy SoC for wearables
OptiPulse develops new type of laser to replace microwaves
Laird Connectivity announces six new GNSS-ready external antennas
Transphorm’s GaN products meet crypto mining power supply units performance requirements
[Design Focus] Digital Step Attenuators (DSAs) for 5G tests and measurements
pSemi's high-performance digital step attenuators (DSAs) feature industry-leading attenuation accuracy. The PE43610 and PE43614 DSAs support the entire 9 kHz–13 GHz and 9 kHz–45 GHz frequency ranges, respectively. Ideal for 5G test-and-measurement applications, these DSAs exemplify pSemi’s high-performance capabilities at mmWave frequencies,
BrainChip’s Akida AI chip detects COVID-19 at hand-held diagnostic testing device
BrainChip BrainChip, a specialist provider of ultra-low power high performance artificial intelligence technology, announced progress in testing with the NaNose (Nano Artificial Nose) where patients’ exhaled breath samples were tested for COVID-19. NaNose Medical Technology, based on the artificial nose developed at the